As of January 22, 2025, iTeos Therapeutics (ITOS) has a market cap of $0.28 billion USD. According to our data, iTeos Therapeutics is ranked No.6773 in global market value.
Year | Market Cap | %Change |
---|---|---|
Jan 22, 2025 | $0.28 B |
0.39%
|
Dec 31, 2024 | $0.28 B |
-29.86%
|
Dec 29, 2023 | $0.40 B |
-43.93%
|
Dec 30, 2022 | $0.71 B |
-58.05%
|
Dec 31, 2021 | $1.70 B |
37.67%
|
Dec 31, 2020 | $1.24 B |
100%
|
Name | Market Cap | Market cap difference | Regions |
---|---|---|---|
Bristol-Myers Squibb
BMY
|
$115.77 B |
0.000 M
|
USA
|
Merck
MRK
|
$242.01 B |
0.005 M
|
USA
|
Pfizer
PFE
|
$147.43 B |
0.004 M
|
USA
|
AstraZeneca
AZN
|
$211.49 B |
0.007 M
|
UK
|
Gilead Sciences
GILD
|
$115.95 B |
0.002 M
|
USA
|
Regeneron Pharmaceuticals
REGN
|
$74.73 B |
1.236 B
|
USA
|
Incyte
INCY
|
$13.95 B |
-0.000 M
|
USA
|
Exelixis
EXEL
|
$9.39 B |
0.000 M
|
USA
|
Blueprint Medicines
BPMC
|
$7.06 B |
-0.000 M
|
USA
|
BeiGene
BGNE
|
$20.21 B |
-0.311 B
|
China
|
Zai Lab
ZLAB
|
$3.03 B |
0.125 B
|
China
|
Arcus Biosciences
RCUS
|
$1.23 B |
-0.000 M
|
USA
|
MacroGenics
MGNX
|
$0.19 B |
-0.000 M
|
USA
|
Adaptimmune Therapeutics
ADAP
|
$0.15 B |
0.000 M
|
UK
|
Market Cap | = | ITOS Stock Price | * | ITOS Shares Outstanding |
= | $7.71 | * | 36.53 M | |
= | $0.28 B |